IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19 and Respiratory Failure
Recorded On: 01/26/2023
Webinar Description:
This session will discuss the challenges of identifying serious complication risks and treating patients with high-risk conditions including severe COVID-19, sepsis, and respiratory failure in emergency departments and intensive care unit settings. The presenter will also discuss Bluejay's Symphony IL-6 test, which has the potential to provide simple, reliable, rapid, near-patient testing by delivering quantitative measurements of IL-6 to determine the need for additional patient care, acute intervention, and monitoring.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Bluejay Diagnostics for this sponsored webinar.
Mark Feinberg, MD
Associate Professor of Medicine
Harvard Medical School
Mark W. Feinberg, MD, is a cardiologist and vascular biologist at Brigham and Women’s Hospital (BWH) and an Associate Professor of Medicine at Harvard Medical School, Boston. Dr. Feinberg is Director, Program in Cardiovascular RNA Biology Research that investigates inflammatory mechanisms leading to the development of a range of macrovascular (e.g. atherosclerosis, coronary, and peripheral artery disease) and microvascular disease states (e.g. diabetes). His group has discovered non-coding RNAs and cardiovascular biomarkers, and has translated these findings into novel therapeutic approaches for ischemic cardiovascular disease. Dr. Feinberg has held various leadership roles in cardiovascular research including his service on international and national peer review study sections, editorial service, and as a Co-Chair of the Brigham Research Institute’s Cardiovascular, Diabetes, and Metabolic Disorders Center. Dr. Feinberg completed his Cardiovascular Medicine fellowship training at Brigham and Women’s Hospital, where he subsequently joined the faculty. Dr. Feinberg was inducted as a member of the American Society of Clinical Investigation and has received several major research awards including an American Heart Association Louis N. and Arnold M. Katz Prize Finalist and the David W. Haack Memorial Award.